We are live on
!
Find out more
DM
Deerfield Management Portfolio holdings
AUM
$8.48B
1-Year Est. Return
99.04%
This Fund
S&P 500
This Quarter
Est. Return
-3.25%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$6.01B
AUM Growth
+$262M
(+4.6%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
51.52%
Holding
592
New
224
Increased
125
Reduced
42
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WAY
Waystar Holding Corp
WAY
|
+$107M |
| 2 |
Gilead Sciences
GILD
|
+$99.5M |
| 3 |
CVS Health
CVS
|
+$61M |
| 4 |
Baxter International
BAX
|
+$57.9M |
| 5 |
Cullinan Oncology
CGEM
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$136M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$80.7M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$63.2M |
| 4 |
Oscar Health
OSCR
|
+$44.4M |
| 5 |
Viking Therapeutics
VKTX
|
+$38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 83.29% |
| 2 | Industrials | 0.69% |
| 3 | Technology | 0.57% |
| 4 | Financials | 0.44% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Aquestive Therapeutics
AQST
$468M
| $380K | 0.01% |
+146,155
| New | +$488K |
|
302
Mercado Libre
MELI
$92.3B
| $378K | 0.01% |
+230
| New | +$363K |
|
303
Inspire Medical Systems
INSP
$1.47B
| $376K | 0.01% |
+2,813
| New | +$532K |
|
304
Blackbaud
BLKB
$1.59B
| $372K | 0.01% |
+4,884
| New | +$376K |
|
305
SLR Investment Corp
SLRC
$705M
| $372K | 0.01% |
23,119
+9,530
| +70% | +$150K |
|
306
Coinbase
COIN
$44.1B
| $370K | 0.01% |
+1,667
| New | +$384K |
|
307
Travelers Companies
TRV
$81.4B
| $365K | 0.01% |
1,794
+543
| +43% | +$117K |
|
308
S&P Global
SPGI
$130B
| $364K | 0.01% |
+817
| New | +$351K |
|
309
MediaAlpha
MAX
$734M
| $364K | 0.01% |
+27,630
| New | +$508K |
|
310
Dolby
DLB
$4.85B
| $363K | 0.01% |
+4,587
| New | +$369K |
|
|
SPR
311
DELISTED
Spirit AeroSystems
SPR
| $348K | 0.01% |
+10,583
| New | +$338K |
|
312
Anavex Life Sciences
AVXL
$232M
| $346K | 0.01% |
+81,890
| New | +$331K |
|
313
National Beverage
FIZZ
$2.93B
| $344K | 0.01% |
+6,713
| New | +$314K |
|
314
Olema Pharmaceuticals
OLMA
$1.05B
| $340K | 0.01% |
+31,405
| New | +$341K |
|
315
Gartner
IT
$9.87B
| $339K | 0.01% |
+754
| New | +$335K |
|
316
Walt Disney
DIS
$168B
| $336K | 0.01% |
+3,386
| New | +$364K |
|
317
BRC Inc
BRCC
$116M
| $335K | 0.01% |
+54,611
| New | +$284K |
|
318
Janus International
JBI
$732M
| $331K | 0.01% |
26,179
+7,640
| +41% | +$107K |
|
319
ON Semiconductor
ON
$34.7B
| $327K | 0.01% |
+4,777
| New | +$335K |
|
320
ANI Pharmaceuticals
ANIP
$1.78B
| $327K | 0.01% |
5,138
+511
| +11% | +$33.2K |
|
321
Genworth Financial
GNW
$3.79B
| $327K | 0.01% |
+54,091
| New | +$336K |
|
322
Mativ Holdings
MATV
$455M
| $320K | 0.01% |
18,877
-507
| -3% | -$9.04K |
|
323
Hallador Energy
HNRG
$717M
| $318K | 0.01% |
+40,892
| New | +$256K |
|
324
Schrodinger
SDGR
$1.14B
| $318K | 0.01% |
+16,428
| New | +$379K |
|
325
Ollie's Bargain Outlet
OLLI
$4.04B
| $316K | 0.01% |
+3,223
| New | +$256K |
|
Similar funds
FT
GRQ
PCM
VA
QC
IC
NW
AAF
Deerfield Management's Q2 2024 Portfolio in Review
As of Q2 2024, Deerfield Management held 592 positions worth $6.01B, up 4.6% from $5.75B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Deerfield Management's Q2 2024 filing shows 224 new, 125 increased, 42 reduced and 159 closed positions. Its largest new stake was Waystar Holding Corp: 4,952,004 shares worth $106M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $136M.
By sector, the portfolio is most concentrated in Healthcare at 83% of assets, down from 89% a quarter earlier, followed by Industrials and Technology.
- Deerfield Management's largest Q2 2024 buy was Waystar Holding Corp: 4,952,004 shares worth $106M.
- Deerfield Management added most to Baxter International in Q2 2024, an estimated $57.9M increase.
- Deerfield Management's biggest Q2 2024 reduction was Oscar Health, cutting an estimated $44.4M.
- Deerfield Management fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $136M.
- Deerfield Management's ten largest holdings make up 52% of its $6.01B portfolio in Q2 2024.
- Deerfield Management opened 224 new positions and closed 159 in Q2 2024.
- Deerfield Management's portfolio value rose 4.6% quarter-over-quarter to $6.01B.
Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.